Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Epilepsy
NCT02889627Phase 3Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Nov 2016
- Primary completion
- Oct 2025
- Modality
- Microbiome Therapeutics, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of washed fecal microbiota in epilepsy, sponsored by The Second Affiliated Hospital of Nanjing Medical University. Started Nov 2016; status: recruiting.
02
Drugs
washed fecal microbiota
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02889627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889627.